Cinacalcet for the treatment of secondary hyperparathyroidism (HPT) in patients non responsive to vitamin D

被引：0
|
作者：
Malberti, Fabio
Villa, Giuseppe
Colussi, Giacomo
Mingardi, Giulio
Quartagno, Rita
Limido, Aurelio
Conte, Ferruccio
Farina, Marco
Montagna, G.
Vezzoli, Giuseppe
Ravani, Pietro
机构：
[1] Ist Ospitalieri, Div Nefrol, Cremona, Italy
[2] Fdn Maugeri, Div Nefrol, Pavia, Italy
[3] Fdn Macchi, Div Nefrol, Varese, Italy
[4] Osped Riuniti Bergamo, Div Nephrol, I-24100 Bergamo, Italy
[5] IRCCS San Raffaele, Div Nefrol, Milan, Italy
[6] Osped Causa Pia Uboldo, Div Nefrol, Cernusco Sul Naviglio, Italy
[7] Osped S Antonio Abate, Div Nefrol, Gallarate, Italy
[8] Osped Maggiore Lodi, Div Nefrol, Lodi, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [11] Cinacalcet: A new treatment for secondary hyperparathyroidism in patients receiving hemodialysis
    Byrnes, CA
    Shepler, BM
    PHARMACOTHERAPY, 2005, 25 (05): : 709 - 716
  • [12] Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism
    Bergua, C.
    Torregrosa, J.-V.
    Cofan, F.
    Oppenheimer, F.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2254 - 2255
  • [13] Cinacalcet for secondary hyperparathyroidism in ESRD patients
    Kirby R.
    Nature Clinical Practice Nephrology, 2006, 2 (1): : 8 - 9
  • [14] Cinacalcet (MIMPARA®/SENSIPAR®) maintains achievement of NKF-K/DOQI treatment targets for secondary hyperparathyroidism (HPT) in patients on dialysis
    Frazao, JM
    Holzer, H
    Stummvoll, HK
    Bahner, U
    Wilkie, M
    Zani, V
    Hutton, H
    Motellon, JL
    Braun, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V89 - V89
  • [15] Cinacalcet HCl is an effective treatment for secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) not yet receiving dialysis.
    Coburn, JW
    Charytan, C
    Chonchol, M
    Herman, J
    Lien, YH
    Liu, W
    Klassen, P
    Yahaghi, AS
    Pichette, V
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 460A - 460A
  • [16] Treatment of secondary hyperparathyroidism with paricalcitol with or without cinacalcet in hemodialysis patients
    Zawierucha, Jacek
    Malyszko, Jolanta
    Malyszko, Jacek S.
    Prystacki, Tomasz
    Marcinkowski, Wojciech
    Dryl-Rydzynska, Teresa
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (12): : 840 - 845
  • [17] Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism
    Block, Geoffrey A.
    Zeig, Steven
    Sugihara, Jared
    Chertow, Glenn M.
    Chi, Eric M.
    Turner, Stewart A.
    Bushinsky, David A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (07) : 2311 - 2318
  • [18] Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials
    Jun Xu
    Yan Yang
    Liang Ma
    Ping Fu
    Hongying Peng
    International Urology and Nephrology, 2019, 51 : 2027 - 2036
  • [19] Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials
    Xu, Jun
    Yang, Yan
    Ma, Liang
    Fu, Ping
    Peng, Hongying
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (11) : 2027 - 2036
  • [20] Vitamin D analogs for the treatment of secondary hyperparathyroidism
    Slatopolsky, E
    Brown, AJ
    BLOOD PURIFICATION, 2002, 20 (01) : 109 - 112
12345